Zealand Pharma Surges on Promising Weight Loss Drug Trial Results by Mark Eisenberg 21.06.2024 Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...
Akero Therapeutics MASH Treatment Trial Data: Stock Up 21% by Mark Eisenberg 04.03.2024 The stock has dropped 29% in the last year, hitting a low of $11.25 on Oct. 27. A study shows ...
Adial Pharmaceuticals Targets $40B Addiction Market by Mark Eisenberg 13.02.2024 Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...